Page last updated: 2024-08-23

simvastatin and Dermatomyositis

simvastatin has been researched along with Dermatomyositis in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	2 (28.57)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borges, IBP; Misse, RG; Shinjo, SK; Silva, MG	1
Didona, B; Didona, D; Fania, L; Mazzanti, C; Tonanzi, T	1
Rasch, A; Sander, CA; Schimmer, M	1
Goebeler, M; Goerdt, S; Inhoff, O; Paredes, BE; Peitsch, WK	1
Ben Osman, A; Chelly, I; Labbène, I; Mokni, M; Mrabet, D; Sellami, S; Zaraa, IR; Zitouna, M; Zribi, H	1
Branford, WA; Khattak, FH; Morris, IM	1
Hill, C; Kirkham, B; Zeitz, C	1

Reviews

1 review(s) available for simvastatin and Dermatomyositis

Article	Year
Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatology international, 2018, Volume: 38, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Bezafibrate; Dermatomyositis; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Immunosuppressive Agents; Male; Middle Aged; Polymyositis; Remission Induction; Retrospective Studies; Risk Factors; Simvastatin; Time Factors; Treatment Outcome	2018

Article

Year

Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review.

Rheumatology international, 2018, Volume: 38, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Bezafibrate; Dermatomyositis; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Immunosuppressive Agents; Male; Middle Aged; Polymyositis; Remission Induction; Retrospective Studies; Risk Factors; Simvastatin; Time Factors; Treatment Outcome

2018

Other Studies

6 other study(ies) available for simvastatin and Dermatomyositis

Article	Year
Simvastatin-associated dermatomyositis. Dermatologic therapy, 2017, Volume: 30, Issue:4 Topics: Aged; Dermatomyositis; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin	2017
[Simvastatin-induced dermatomyositis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2009, Volume: 60, Issue:6 Topics: Aged; Anticholesteremic Agents; Dermatomyositis; Female; Humans; Simvastatin	2009
Simvastatin-induced amyopathic dermatomyositis. The British journal of dermatology, 2009, Volume: 161, Issue:1 Topics: Aged; Biopsy; Dermatomyositis; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Paraneoplastic Syndromes; Simvastatin; Treatment Outcome	2009
Simvastatin-induced dermatomyositis in a 50-year-old man. BMJ case reports, 2011, Mar-29, Volume: 2011 Topics: Dermatomyositis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Simvastatin	2011
Simvastatin-associated dermatomyositis. British journal of rheumatology, 1994, Volume: 33, Issue:2 Topics: Dermatomyositis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Simvastatin	1994
Dermatomyositis with lung involvement in a patient treated with simvastatin. Australian and New Zealand journal of medicine, 1995, Volume: 25, Issue:6 Topics: Aged; Anticholesteremic Agents; Biopsy; Dermatomyositis; Fatal Outcome; Female; Humans; Hypercholesterolemia; Lovastatin; Lung Diseases; Muscle, Skeletal; Simvastatin	1995